The biology of Epstein-Barr virus: lessons learned from the virus and the host

被引：37

作者：

Cohen, JI ^{[1
]}

机构：

[1] NIH, Med Virol Sect, Clin Invest Lab, Bethesda, MD 20892 USA

来源：

CURRENT OPINION IN IMMUNOLOGY | 1999年 / 11卷 / 04期

关键词：

D O I：

10.1016/S0952-7915(99)80062-4

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Recent studies indicate that a large proportion of cytotoxic T cells are directed towards the Epstein-Barr virus (EBV) during both acute infection and convalescence. The virus, in turn, has usurped cellular pathways to promote proliferation of infected cells and has pirated cellular genes into its genome to modulate the immune system to allow lifelong infection of humans. Analysis of the immune response to the virus is leading to novel therapies for EBV-associated malignancies, including the use of virus-specific cytotoxic T cell infusions.

引用

页码：365 / 370

页数：6

共 51 条

[1] EBV persistence in memory B cells in vivo [J].

Babcock, GJ ;

Decker, LL ;

Volk, M ;

Thorley-Lawson, DA .

IMMUNITY, 1998, 9 (03) :395-404

[2] Human CD8+ T cell responses to EBV EBNA1:: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing [J].

Blake, N ;

Lee, S ;

Redchenko, I ;

Thomas, W ;

Steven, N ;

Leese, A ;

Steigerwald-Mullen, P ;

Kurilla, MG ;

Frappier, L ;

Rickinson, A .

IMMUNITY, 1997, 7 (06) :791-802

[3]

Busch LK, 1999, J IMMUNOL, V162, P2555

[4] Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals [J].

Caldwell, RG ;

Wilson, JB ;

Anderson, SJ ;

Longnecker, R .

IMMUNITY, 1998, 9 (03) :405-411

[5] Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo [J].

Callan, MFC ;

Tan, L ;

Annels, N ;

Ogg, GS ;

Wilson, JDK ;

O'Callaghan, CA ;

Steven, N ;

McMichael, AJ ;

Rickinson, AB .

JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (09) :1395-1402

[6] Large clonal expansions of CD8(+) T cells in acute infectious mononucleosis [J].

Callan, MFC ;

Steven, J ;

Krausa, P ;

Wilson, JDK ;

Moss, PAH ;

Gillespie, GM ;

Bell, JI ;

Rickinson, AB ;

McMichael, AJ .

NATURE MEDICINE, 1996, 2 (08) :906-911

[7] Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype [J].

Chodosh, J ;

Bolder, VP ;

Gan, YJ ;

Belgaumi, A ;

Sample, J ;

Sixbey, JW .

JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (05) :1194-1201

[8] Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene [J].

Coffey, AJ ;

Brooksbank, RA ;

Brandau, O ;

Oohashi, T ;

Howell, GR ;

Bye, JM ;

Cahn, AP ;

Durham, J ;

Heath, P ;

Wray, P ;

Pavitt, R ;

Wilkinson, J ;

Leversha, M ;

Huckle, E ;

Shaw-Smith, CJ ;

Dunham, A ;

Rhodes, S ;

Schuster, V ;

Porta, G ;

Yin, L ;

Serafini, P ;

Sylla, B ;

Zollo, M ;

Franco, B ;

Bolino, A ;

Seri, M ;

Lanyi, A ;

Davis, JR ;

Webster, D ;

Harris, A ;

Lenoir, G ;

St Basile, GD ;

Jones, A ;

Behloradsky, BH ;

Achatz, H ;

Murken, J ;

Fassler, R ;

Sumegi, J ;

Romeo, G ;

Vaudin, M ;

Ross, MT ;

Meindl, A ;

Bentley, DR .

NATURE GENETICS, 1998, 20 (02) :129-135

[9] Epstein-Barr virus and the immune system - Hide and seek [J].

Cohen, JI .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (06) :510-513

[10] Functional differences between BHRF1, the Epstein-Barr virus-encoded Bcl-2 homologue, and Bcl-2 in human epithelial cells [J].

Dawson, CW ;

Dawson, J ;

Jones, R ;

Ward, K ;

Young, LS .

JOURNAL OF VIROLOGY, 1998, 72 (11) :9016-9024

← 1 2 3 4 5 6 →